Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

Constipation Treatment Market Constipation Treatment Market Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Constipation Treatment - Global Strategic Business Report" has been added to ...

Researchers have discovered a new mechanism that is used by a male sex hormone essential for muscle and bone function. The ...

Researchers at the Center for Life Sciences at the Paul Scherrer Institute PSI have for the first time identified structural ...

ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

Entero Therapeutics, Inc. (Nasdaq: ENTO) ("Entero” or the "Company”), a clinical-stage biopharmaceutical company specializing ...